A recent surge in scientific publications has found preclinical and clinical evidence documenting value for CBD in some neuropsychiatric disorders.Evidence points toward a calming effect for CBD in the central nervous system.
Interest in CBD as a treatment of a wide range of disorders has exploded, yet few clinical studies of CBD exist in the psychiatric literature.
Unlike some past studies which showed that CBD helped to reduce SYMPTOMS at higher dosage levels (300mg/day), this study showed that patients were able to reduce their anxiousness with as little as 25mg/day.